Nicotinamide Adenine Dinucleotide

Image: iStockPhoto

Niagen nicotinamide riboside may reduce obesity-related inflammation

By Stephen Daniells

Nicotinamide riboside, a vitamin B3 derivative, may reduce inflammation linked to obesity, and reduce the risk of diseases linked to this type of inflammation, according to pre-clinical data from scientists at the National Institutes of Health.

Chromadex cements position in NR market with third IP acquisition

Chromadex cements position in NR market with third IP acquisition

By Hank Schultz

Chromadex has announced a licensing deal with Washington University in St. Louis for the worldwide exclusive patent rights related to the recently discovered vitamin nicotinamide riboside (NR). It is Chromadex’s third IP acquisition related to the molecule.

A vitamin found naturally in milk, NR is a more potent version of niacin (vitamin B3) and a precursor to nicotinamide adenine dinucleotide (NAD), increased cellular levels of which have multiple health benefits, says ChromaDex

ChromaDex gears up for launch of next generation niacin ingredient

By Elaine Watson

ChromaDex is gearing up for a commercial launch of Nicotinamide riboside (NR) - a next generation version of vitamin B3 (niacin) claimed to help protect the brain, battle the bulge and improve blood glucose control - at the end of this year or early next.


Follow us


View more


Featured Suppliers